Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel radionuclide therapy combinations in prostate cancer.
Inderjeeth AJ, Iravani A, Subramaniam S, Conduit C, Sandhu S. Inderjeeth AJ, et al. Among authors: conduit c. Ther Adv Med Oncol. 2023 Aug 2;15:17588359231187202. doi: 10.1177/17588359231187202. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37547444 Free PMC article. Review.
Improving outcomes in germ cell cancers using miRNA.
Conduit C, Tran B. Conduit C, et al. Ther Adv Med Oncol. 2021 Jun 30;13:17588359211027826. doi: 10.1177/17588359211027826. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34262617 Free PMC article. Review.
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).
Conduit C, Mak B, Qu W, Lulio JD, Burder R, Bressel M, Cusick T, Dhillon HM, Lourenço RA, Underhill C, Torres J, Crumbaker M, Honeyball F, Linton A, Allen R, Davis ID, Clark SJ, Horvath LG, Mahon KL. Conduit C, et al. Ther Adv Med Oncol. 2022 Apr 18;14:17588359221092486. doi: 10.1177/17588359221092486. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35465297 Free PMC article.
A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours.
Conduit C, Hong W, Martin F, Thomas B, Lawrentschuk N, Goad J, Grimison P, Ahmadi N, Tran B, Lewin J. Conduit C, et al. Front Oncol. 2022 Aug 17;12:931509. doi: 10.3389/fonc.2022.931509. eCollection 2022. Front Oncol. 2022. PMID: 36059636 Free PMC article.
Treatment de-escalation for stage II seminoma.
Wood GE, Chamberlain F, Tran B, Conduit C, Liow E, Nicol DL, Shamash J, Alifrangis C, Rajan P. Wood GE, et al. Among authors: conduit c. Nat Rev Urol. 2023 Aug;20(8):502-512. doi: 10.1038/s41585-023-00727-0. Epub 2023 Mar 7. Nat Rev Urol. 2023. PMID: 36882564 Review.
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations.
Conduit C, Lewin J, Weickhardt A, Lynam J, Wong S, Grimison P, Sengupta S, Pranavan G, Parnis F, Bastick P, Campbell D, Hansen AR, Leonard M, McJannett M, Stockler MR, Gibbs P, Toner G, Davis ID, Tran B, Kuchel A. Conduit C, et al. JCO Oncol Pract. 2023 Nov;19(11):973-980. doi: 10.1200/OP.23.00191. Epub 2023 Jun 16. JCO Oncol Pract. 2023. PMID: 37327464
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.
Roberts MJ, Conduit C, Davis ID, Effeney RM, Williams S, Martin JM, Hofman MS, Hruby G, Eapen R, Gianacas C, Papa N, Lourenço RA, Dhillon HM, Allen R, Fontela A, Kaur B, Emmett L; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Roberts MJ, et al. Among authors: conduit c. BJU Int. 2024 Feb;133 Suppl 3:39-47. doi: 10.1111/bju.16158. Epub 2023 Sep 14. BJU Int. 2024. PMID: 37604702
32 results